Stephen J. Boccuzzi - Concepedia

Author

Stephen J. Boccuzzi

Also Known As

S Boccuzzi, S J Boccuzzi, S. Boccuzzi, S. J. Boccuzzi, S.J. Boccuzzi, Stephen Boccuzzi, Stephen J Boccuzzi, Stephen J. Boccuzzi

Publications

4.4K

Citations

H-Index

Concepts

All Affiliations

Emory University United States Military Academy Merck & Co., Inc., Rahway, NJ, USA (United States)Aetna (United States)Thomas Jefferson University

About

Stephen J. Boccuzzi is an author at Emory University specializing in cardiovascular disease, medicine, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	1.3K
2	Public Health	6	6	390
3	Engineering	1	1	24
4	Health Sciences	1	1	35
5	Anatomy	1	1	27

Stephen J. Boccuzzi

Publications

4.3K

Citations

H-Index

Page 1

	Year	Citations
Beneficial Effects of Cholesterol-Lowering Therapy on the Coronary Endothelium in Patients with Coronary Artery Disease J. Larry Klein, William S. Weintraub, Michael Stillabower, New England Journal of Medicine	1995	1.1K
Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group. Robert E. Goldstein, Stephen J. Boccuzzi, David F. Cruess, Circulation Heart FailureCardiovascular PharmacologyDiltiazem EffectDiastolic FunctionAcute Myocardial Infarction	1991	523
Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial. David D. Waters, Lyall Higginson, Peter Gladstone, Circulation	1994	505
Economic burden of deep-vein thrombosis, pulmonary embolism, and post-thrombotic syndrome D. MacDougall, Anthony L. Feliu, Stephen J. Boccuzzi, American Journal of Health-System Pharmacy	2006	300
Lack of Effect of Lovastatin on Restenosis after Coronary Angioplasty William Weintraub, Stephen J. Boccuzzi, J. Larry Klein, New England Journal of Medicine	1994	291
Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease Carla A. Sueta, Mridul Chowdhury, Stephen J. Boccuzzi, The American Journal of Cardiology Heart FailureCardiovascular DiseaseCoronary Artery DiseaseHyperlipidemiaDyslipidemia	1999	266
Four-year persistence patterns among patients initiating therapy with the angiotensin II receptor antagonist losartan versus other antihypertensive drug classes Paul R. Conlin, William C. Gerth, James M. Fox, Clinical Therapeutics Non-pharmacological InterventionHypertensionCardiovascular DiseaseAntihypertensive TherapyPharmacology	2001	184
Utilization of Oral Hypoglycemic Agents in a Drug-Insured U.S. Population Stephen J. Boccuzzi, Jenifer Wogen, James M. Fox, Diabetes Care	2001	181
Effects of Cigarette Smoking on the Angiographic Evolution of Coronary Atherosclerosis David D. Waters, Jacques Lespe ́rance, Peter Gladstone, Circulation	1996	122
Long-term safety and efficacy profile of simvastatin Stephen J. Boccuzzi, Tomás S. Bocanegra, J. Findlay Walker, The American Journal of Cardiology Drug SafetyThrombosisCardiovascular DiseaseMedicineEfficacy Profile	1991	114

Page 1